A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
Improvement in the rate of bacterial translocation may lead to a decrease in a chronic
inflammatory response thereby decreasing CD4 destruction and HIV proliferation.
By the addition of probiotics we hope to show a reduction in LPS leading to a decrease in
chronic inflammation and therefore an improvement in immune markers.